Healthia Dirección
Dirección controles de criterios 3/4
El CEO de Healthia es Wes Coote , nombrado en Apr 2019, tiene una permanencia de 4.67 años. compensación anual total es A$660.60K, compuesta por 60.2% salario y 39.8% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.42% de las acciones de la empresa, por valor de A$3.58M. La antigüedad media del equipo directivo y de la junta directiva es de 1.4 años y 5.6 años, respectivamente.
Información clave
Wes Coote
Chief Executive Officer (CEO)
AU$660.6k
Compensación total
| Porcentaje del salario del CEO | 60.2% |
| Permanencia del CEO | 4.7yrs |
| Participación del CEO | 1.4% |
| Permanencia media de la dirección | 1.4yrs |
| Promedio de permanencia en la Junta Directiva | 5.6yrs |
Actualizaciones recientes de la dirección
Recent updates
Calculating The Fair Value Of Healthia Limited (ASX:HLA)
Jan 30
Healthia (ASX:HLA) Has Re-Affirmed Its Dividend Of AU$0.02
Mar 02Here's Why Healthia Limited's (ASX:HLA) CEO May Deserve A Raise
Nov 09Earnings Tell The Story For Healthia Limited (ASX:HLA) As Its Stock Soars 30%
Sep 17Healthia Limited (ASX:HLA) Stocks Shoot Up 30% But Its P/E Still Looks Reasonable
Sep 17Healthia (ASX:HLA) Is Increasing Its Dividend To AU$0.025
Sep 01I Ran A Stock Scan For Earnings Growth And Healthia (ASX:HLA) Passed With Ease
Aug 17Is Now An Opportune Moment To Examine Healthia Limited (ASX:HLA)?
May 19Is Healthia (ASX:HLA) A Risky Investment?
Apr 19With EPS Growth And More, Healthia (ASX:HLA) Is Interesting
Apr 03Announcing: Healthia (ASX:HLA) Stock Increased An Energizing 108% In The Last Year
Mar 19Insider Buying: The Healthia Limited (ASX:HLA) Independent Non-Executive Director Just Bought 4.7% More Shares
Mar 06What Kind Of Shareholders Hold The Majority In Healthia Limited's (ASX:HLA) Shares?
Feb 26Is There Now An Opportunity In Healthia Limited (ASX:HLA)?
Feb 09Healthia Limited's (ASX:HLA) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?
Jan 19Why Dividend Hunters Love Healthia Limited (ASX:HLA)
Dec 29Did You Miss Healthia's (ASX:HLA) 13% Share Price Gain?
Dec 10We're Not So Sure You Should Rely on Healthia's (ASX:HLA) Statutory Earnings
Nov 20
Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Jun 30 2023 | AU$661k | AU$398k | AU$5m |
| Mar 31 2023 | n/a | n/a | AU$3m |
| Dec 31 2022 | n/a | n/a | AU$781k |
| Sep 30 2022 | n/a | n/a | -AU$1m |
| Jun 30 2022 | AU$516k | AU$345k | -AU$3m |
| Mar 31 2022 | n/a | n/a | -AU$2m |
| Dec 31 2021 | n/a | n/a | AU$161k |
| Sep 30 2021 | n/a | n/a | AU$3m |
| Jun 30 2021 | AU$400k | AU$306k | AU$5m |
| Mar 31 2021 | n/a | n/a | AU$6m |
| Dec 31 2020 | n/a | n/a | AU$7m |
| Sep 30 2020 | n/a | n/a | AU$5m |
| Jun 30 2020 | AU$313k | AU$225k | AU$3m |
| Mar 31 2020 | n/a | n/a | AU$1m |
| Dec 31 2019 | n/a | n/a | AU$271k |
| Sep 30 2019 | n/a | n/a | -AU$483k |
| Jun 30 2019 | AU$226k | AU$176k | -AU$1m |
Compensación vs. Mercado: La compensación total ($USD439.78K) de Wes está en línea con el promedio de empresas de tamaño similar en el mercado Australian ($USD708.27K).
Compensación vs. Ingresos: La compensación de Wes ha sido consistente con los resultados de la empresa en el último año.
CEO
Wes Coote
4.7yrs
Permanencia
AU$660,599
Compensación
Mr. Wesley James Coote, also known as Wes, B.Com., C.A., ACIS, serves as the Managing Director of Evolve Salons Limited. Mr. Coote has been Group Managing Director, Chief Executive Officer and Director at...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Group MD | 4.7yrs | AU$660.60k | 1.42% A$ 3.6m | |
| Group Chief Financial Officer | less than a year | AU$319.83k | sin datos | |
| Director of Podiatry & Executive Director | no data | AU$115.34k | 6.4% A$ 16.1m | |
| Group Chief Partnerships Officer & Executive Director | less than a year | AU$391.84k | 0.75% A$ 1.9m | |
| CEO of Eyes & Ears Division and Director | 2.7yrs | AU$368.92k | 3.66% A$ 9.2m | |
| Chief Executive Officer of Bodies | less than a year | AU$314.24k | sin datos | |
| Chief Technology Officer | 1.9yrs | AU$261.49k | 2.49% A$ 6.3m | |
| General Counsel & Company Secretary | 1.8yrs | sin datos | sin datos | |
| Group Chief Business Development & Strategy Officer | no data | AU$341.32k | 0% A$ 0 | |
| Group Chief Education & Research Officer | no data | sin datos | sin datos | |
| Chief Operating Officer of Eyes & Ears Division | less than a year | sin datos | sin datos |
1.4yrs
Permanencia media
Equipo directivo experimentado: El equipo directivo de HLA no se considera experimentado ( 1.4 años antigüedad media), lo que sugiere un nuevo equipo.
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Group MD | 4.7yrs | AU$660.60k | 1.42% A$ 3.6m | |
| Director of Podiatry & Executive Director | 5.6yrs | AU$115.34k | 6.4% A$ 16.1m | |
| Group Chief Partnerships Officer & Executive Director | 1.7yrs | AU$391.84k | 0.75% A$ 1.9m | |
| CEO of Eyes & Ears Division and Director | 2.7yrs | AU$368.92k | 3.66% A$ 9.2m | |
| Non-Executive Chairman | 5.6yrs | AU$130.00k | 5.67% A$ 14.3m | |
| Independent Non-Executive Director | 5.6yrs | AU$80.00k | 2.51% A$ 6.3m | |
| Independent Non-Executive Director | 5.6yrs | AU$80.00k | 0.034% A$ 85.2k |
5.6yrs
Permanencia media
Junta con experiencia: La junta directiva de HLA se considera experimentada (5.6 años de antigüedad promedio).